Related Experiment Video
Updated: Jul 15, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Central Diabetes Insipidus: An Acute Manifestation of COVID-19 Infection
Sharanya Suresh Kumar1, Kiran Kumar2, Sneha Venkataramani3
1General Medicine, Thumbay University Hospital, Ajman, ARE.
Abstract:
In recent years, there has been a rise in the number of COVID-19 cases and its complications. Central diabetes insipidus (central DI) is a rare but treatable manifestation of acute COVID-19 infection. This case reports the rapid onset of central DI in a 35-year-old male in less than two weeks post-COVID-19 infection. He made a complete recovery post-administration of desmopressin within one month. Prompt diagnosis, treatment, and periodic follow-up are hence the cornerstones of a successful recovery for a patient with central DI post-COVID-19 infection.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Acute Pancreatitis II: Clinical Manifestations and Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Chronic Kidney Disease II: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Acute Pyelonephritis I: Introduction

